<scp> <i>WDR34</i> </scp> , a candidate gene for non‐syndromic rod‐cone dystrophy
Maria Solaguren‐Beascoa(Centre National de la Recherche Scientifique), Christina Zeitz(Centre National de la Recherche Scientifique), Marion Neuillé(Centre National de la Recherche Scientifique), Marie‐Elise Lancelot(Centre National de la Recherche Scientifique), Vanessa Démontant(Centre National de la Recherche Scientifique), Isabelle Audo(Inserm), Thierry Léveillard(Centre National de la Recherche Scientifique), Mélanie Letexier(Genopole (France)), Cécile Méjécase(Centre National de la Recherche Scientifique), Eric A. Pierce(Broad Institute), Lisa Emmenegger(Centre National de la Recherche Scientifique), José‐Alain Sahel(University of Pittsburgh), Hélène Dollfus(Inserm), Christelle Michiels(Centre National de la Recherche Scientifique), Christine Lonjou(Inserm), Saddek Mohand‐Saïd(Institut de la Vision), Christel Condroyer(University of Namur), Jean‐Paul Saraiva(IntegraGen (France)), Elise Orhan(Centre National de la Recherche Scientifique), Shomi S. Bhattacharya(Centro Andaluz de Biología Molecular y Medicina Regenerativa), Wassila Carpentier(MACOM (United States)), Aline Antonio(Centre National de la Recherche Scientifique), Kinga M. Bujakowska(Massachusetts Eye and Ear Infirmary)
Cited by 12
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k